Veterinary Medicines

CEVAC IBD L lyophilisate for oral suspension

Authorised
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
Download as PDF

Product identification

Medicine name:
СЕВАК АйБиДи Ел лиофилизат за перорална суспензия
CEVAC IBD L lyophilisate for oral suspension
Active substance:
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
Target species:
  • Chicken (chick)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
    2.00
    log 10 50% embryo lethal dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1884
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/04/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 20/10/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 24/04/2025
Download